Identical twins with macrophagic myofasciitis: Genetic susceptibility and triggering by aluminic vaccine adjuvants?

Arthritis Care and Research

Volumn 47, Issue 5, 2002, Pages 543-545

  Guis, S ^a   Mattei, J P ^a   Nicoli, F ^b   Pellissier, J F ^c   Kaplanski, G ^a   Figarella Branger, D ^c   Manez, G C ^a   Antipoff, G M ^a   Roudier, J ^d  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c TIMONE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FASCIITIS; FEMALE; FEVER; GENETIC SUSCEPTIBILITY; HUMAN; MACROPHAGIC MYOFASCIITIS; MUSCLE WEAKNESS; MYALGIA; VACCINATION;

EID: 0037109287     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10666     Document Type: Article

References (6)

1. Gherardi RK, Coquet M, Cherin P, Authier FJ, Laforêt P, Bélec L, et al. Macrophagic myofasciitis: An emerging entity. Lancet 1998;352:347-52.
2. Cherin P, Gherardi RK. Macrophagic myofasciitis. Curr Rheumatol Rep 2000;2:196-200.
3. Gherardi RK, Coquet M, Belec L, Chariot P, Moretto P, Figarella-Branger D, et al. Macrophagic myofasciitis: A reaction to intramuscular injections of aluminum-containing vaccines [abstract]. J Neurol 1999;246 Suppl 1:I19.
4. Misbash SA, Ozols B, Franks A, Mapstone N. Whipple's disease without malabsorption: New atypical features. Q J Med 1997;90:765-72.
5. Helliwell TR, Appleton RE, Mapstone NC, Davidson J, Walsh KP. Dermatomyositis and Whipple's disease. Neuromuscul Disord 2000;10:46-51.
6. McDermott AB, Zuckermann JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997;50:8-14.